Blueprint Financial Statements From 2010 to 2026
| BPMCDelisted Stock | USD 129.46 0.11 0.09% |
Check Blueprint Medicines financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Blueprint Medicines' main balance sheet or income statement drivers, such as , as well as many indicators such as . Blueprint financial statements analysis is a perfect complement when working with Blueprint Medicines Valuation or Volatility modules.
Blueprint |
Blueprint Medicines Corp Company Operating Margin Analysis
Blueprint Medicines' Operating Margin shows how much operating income a company makes on each dollar of sales. It is one of the profitability indicators which helps analysts to understand whether the firm is successful or not making money from everyday operations.
Current Blueprint Medicines Operating Margin | (0.28) % |
Most of Blueprint Medicines' fundamental indicators, such as Operating Margin, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Blueprint Medicines Corp is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
A good Operating Margin is required for a company to be able to pay for its fixed costs or payout its debt, which implies that the higher the margin, the better. This ratio is most effective in evaluating the earning potential of a company over time when comparing it against a firm's competitors.
CompetitionBased on the recorded statements, Blueprint Medicines Corp has an Operating Margin of -0.275%. This is 99.22% lower than that of the Biotechnology sector and 99.75% lower than that of the Health Care industry. The operating margin for all United States stocks is 95.01% lower than that of the firm.
Blueprint Medicines Corp Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Blueprint Medicines's current stock value. Our valuation model uses many indicators to compare Blueprint Medicines value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Blueprint Medicines competition to find correlations between indicators driving Blueprint Medicines's intrinsic value. More Info.Blueprint Medicines Corp is rated below average in return on equity category among its peers. It is rated third in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Blueprint Medicines' earnings, one of the primary drivers of an investment's value.About Blueprint Medicines Financial Statements
Blueprint Medicines stakeholders use historical fundamental indicators, such as Blueprint Medicines' revenue or net income, to determine how well the company is positioned to perform in the future. Although Blueprint Medicines investors may analyze each financial statement separately, they are all interrelated. For example, changes in Blueprint Medicines' assets and liabilities are reflected in the revenues and expenses on Blueprint Medicines' income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Blueprint Medicines Corp. Please read more on our technical analysis and fundamental analysis pages.
Blueprint Medicines Corporation, a precision therapy company, develops medicines for genomically defined cancers and blood disorders in the United States and internationally. Blueprint Medicines Corporation was incorporated in 2008 and is headquartered in Cambridge, Massachusetts. Blueprint Medicines operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 580 people.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors. You can also try the Competition Analyzer module to analyze and compare many basic indicators for a group of related or unrelated entities.
Other Consideration for investing in Blueprint Stock
If you are still planning to invest in Blueprint Medicines Corp check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Blueprint Medicines' history and understand the potential risks before investing.
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges |